QID 355249

Date Published: 2023-05-29

QID 355249: Amazon Linux Security Advisory for maven-shared-utils : ALAS2023-2023-077

Org.apache.maven.shared:maven-shared-utils is a functional replacement for plexus-utils in maven.
Affected versions of this package are vulnerable to command injection.
The commandline class can emit double-quoted strings without proper escaping, allowing shell injection attacks.
The bourneshell class should unconditionally single-quote emitted strings (including the name of the command itself being quoted), with {{\'"\'"\'}} used for embedded single quotes, for maximum safety across shells implementing a superset of posix quoting rules. (
( CVE-2022-29599)



Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a securitybreach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as Critical - 9.8 severity.
  • CVSS V2 rated as High - 7.5 severity.
    • Solution
    Please refer to Amazon advisory: ALAS2023-2023-077 for affected packages and patching details, or update with your package manager.
    Vendor References

    CVEs related to QID 355249

    CVE-2022-29599 |
    Software Advisories
    Advisory ID Software Component Link
    ALAS2023-2023-077 amazon linux 2023 URL Logo alas.aws.amazon.com/AL2023/ALAS-2023-077.html
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].